Background/Objectives: Artificial intelligence (AI) systems may enhance diagnostic accuracy in cone-beam computed tomography (CBCT) analysis. However, most validations focus on isolated tooth-level tasks rather than clinically meaningful full-mouth assessment outcomes. To evaluate the diagnostic accuracy of a commercial AI platform for detecting dental treatment features on CBCT images at both tooth and full-scan levels. Methods: In this retrospective single-center study, 147 CBCT scans (4704 tooth positions) were analyzed. Two experienced readers annotated treatment features (missing teeth, fillings, endodontic treatments, crowns, pontics, orthodontic appliances, implants), and consensus served as the reference. Anonymized datasets were processed by a cloud-based AI system (Diagnocat Inc., San Francisco, CA, USA). Diagnostic metrics—sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1-score—were calculated with 95% patient-clustered bootstrap confidence intervals. A “Perfect Agreement” criterion defined full-scan level success as an entirely error-free full-mouth report. Results: Tooth-level AI performance was excellent, with accuracy exceeding 99% for most categories. Sensitivity was highest for missing teeth (99.3%) and endodontic treatments (99.0%). Specificity and NPV exceeded 98.5% and 99.7%, respectively. Full-scan level Perfect Agreement was achieved in 82.3% (95% CI: 76.2–88.4%), with errors concentrated in teeth presenting multiple co-existing findings. Conclusions: The evaluated AI platform demonstrates near-perfect accuracy in detecting isolated dental features but moderate reliability in generating complete full-mouth reports. It functions best as an assistive diagnostic tool, not as an autonomous system.
Background/Objective: To evaluate the reliability, diagnostic accuracy and time efficiency of an artificial intelligence (AI)-automated method (CephX) and a semiautomated method (INVIVO) for upper airway segmentation, the manual digital method (ITK-SNAP) was used as the reference standard. Methods: This retrospective study analyzed cone-beam computed tomography (CBCT) scans from 133 patients. The upper airway volume and narrowest cross-sectional area were measured via the three methods. Reliability and repeatability were assessed via the intraclass correlation coefficient (ICC). The time required for each segmentation method was also recorded and compared. Results: Both the AI-automated (ICC = 0.945) and semiautomated (ICC = 0.992) methods demonstrated excellent reliability for total volume measurements compared with the manual reference. For the narrowest area, the automated method showed excellent agreement (ICC = 0.943), whereas the semiautomated method showed good agreement (ICC = 0.868). All methods demonstrated excellent intrareader repeatability (ICC > 0.95) and high test–retest reliability. The AI-automated method was significantly more time-efficient, requiring less than 30 s per analysis, compared with 161.4 s for the semiautomated method and 336.6 s for the manual method. Conclusions: AI-automated and semiautomated segmentation methods are reliable and accurate alternatives to manual upper airway analysis. The AI-based approach offers a substantial advantage in time efficiency, making it a valuable tool for clinical practice.
Metabolic syndrome (MetS), a multifactorial condition characterized by insulin resistance, visceral obesity, dyslipidemia, hypertension, and hyperglycemia, is a growing global health concern. Emerging evidence indicates potential links between MetS and various skin diseases, suggesting shared underlying pathophysiological mechanisms. This review explores these associations, emphasizing that MetS’s pro-inflammatory state and hormonal imbalances may trigger or exacerbate dermatological conditions. Sebaceous and apocrine gland dysfunctions related to androgen excess highlight the link between acne vulgaris and elevated mTORC1 signaling, a marker of insulin resistance. Acne rosacea, similarly, shows an association with systemic inflammation and MetS comorbidities. Hidradenitis suppurativa, a chronic apocrine gland disorder, is notably more prevalent in individuals with obesity and socioeconomic disadvantages, underscoring complex metabolic and environmental interdependencies. The relationship between atopic dermatitis (AD) and MetS remains contested, though central obesity appears to be a common link. Psoriasis consistently correlates with higher MetS incidence, reinforcing the need for cardiovascular monitoring in these patients. Vitiligo, through autoimmune and inflammatory mechanisms, has been linked to metabolic disturbances, while androgenetic alopecia and acanthosis nigricans further exemplify insulin resistance’s dermatological manifestations. Although seborrheic dermatitis and lichen planus have yielded inconsistent data regarding MetS, notable associations exist. Overall, the review underlines the bidirectional impact between skin conditions and metabolic dysfunctions, advocating for interdisciplinary management to mitigate cardiovascular risks and improve patient outcomes. Future research is necessary to elucidate causal relationships and refine treatment strategies that address both metabolic and dermatological health. Keywords: metabolic syndrome acne atopic dermatitis psoriasis vitiligo androgenetic alopecia seborrheic dermatitis lichen planus acanthosis nigricans
Background/Objectives: The objective of our study was to compare the diagnostic performance of a popular, commercial dental artificial intelligence (AI) platform (Diagnocat, DGNCT LLC, Miami, FL, USA) for detecting maxillary sinus abnormalities on paired panoramic radiographs (OPG) and cone-beam computed tomography (CBCT) acquired in the same patients, and to examine whether lesion conspicuity predicts correct AI decisions. Methods: In this retrospective paired study, 166 patients contributed 332 maxillary sinuses with OPG and CBCT performed ≤30 days apart. The reference standard was consensus CBCT reading by two observers with third-reader arbitration. The index test was the AI’s sinus-level binary output (any abnormality). Accuracy, precision, recall, and F1 score were estimated with patient-clustered 95% bootstrap CIs; secondary analyses assessed category-specific performance and the effect of mucosal thickness and polyp/cyst volume. Results: Our evaluation showed that the platform’s performance depended on modality. On CBCT, the accuracy was 69.88% (64.76–74.70%), precision was 87.83% (81.58–93.33%), recall was 54.01% (46.74–61.17%), and F1 score was 66.89% (60.34–72.84%). On OPG, the accuracy was 50.6% (44.58–55.41%), precision was 67.80% (55.38–79.66%), recall was 21.39% (15.62–27.32%), and F1 score 32.52% (24.79–39.69%). On CBCT, higher mucosal thickness and larger polyp/cyst volume strongly predicted correct AI calls; no such effect was seen with OPG. Conclusions: In conclusion, the evaluated AI showed high precision but only moderate recall on CBCT and unreliable performance on OPG. Outputs must be interpreted by a professional; AI alerts on OPG should not guide management without CBCT confirmation.